Remove 2022 Remove Clinic Remove Mammogram
article thumbnail

AI's impact on false-positive mammograms, breast cancer screening performance

AuntMinnie

million mammograms were performed in the U.S. Although mammogram is the most widely used screening modality, a known problem is that 9.5% As is common in Europe, NHS currently uses a two-radiologist reader assessment of breast mammograms, three when there is disagreement. Just over 40.5

Mammogram 105
article thumbnail

Lunit AI Releases Successful Study Results on Breast Cancer Screening Deployment

Imaging Technology

The original ScreenTrustCAD trial (2021–2022), published in The Lancet Digital Health , was the first prospective interventional study to demonstrate that AI could match or even surpass traditional two-radiologist systems. Previously, the waiting time for a clinical mammogram was five to six weeks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

RadNet testing three retail in-store breast cancer screening operations

AuntMinnie

RadNet executives will spend the next 18 months learning what does and doesn't work for operating small in-store retail breast cancer screening clinics in three areas of the U.S. In early December 2023, the first of RadNet's three pilot MammogramNow clinics opened in a Walmart Supercenter in Milford, DE. Then, in 2022, the U.S.

Insurance 124
article thumbnail

ScreenPoint Medical: Transpara Breast AI Demonstrates Value in Real-world Clinical Usage

Imaging Technology

milla1cf Wed, 05/03/2023 - 22:26 May 3, 2023 — ScreenPoint Medical announced today that its Transpara breast AI has surpassed 4 million mammograms (2D and 3D) analyzed in support of radiologists. Widely used in Europe and the US, the milestone of 4 million mammograms analyzed was reached at Denmark's Capital region screening program.

Clinic 52
article thumbnail

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

Imaging Technology

This regulatory approval further validates the clinical efficacy of our technology, paving the way for its use in healthcare facilities across Canada, where breast cancer accounts for approximately 25% of new cases of cancer and 13% of all cancer deaths in Canadian women. 2022 May 11. Journal of Clinical Oncology.

article thumbnail

Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment

Imaging Technology

This regulatory approval further validates the clinical efficacy of our technology, paving the way for its use in healthcare facilities across Canada, where breast cancer accounts for approximately 25% of new cases of cancer and 13% of all cancer deaths in Canadian women. 2022 May 11. Journal of Clinical Oncology.

article thumbnail

ACS: Breast cancer mortality decreases, disparities persist

AuntMinnie

“Disparities in breast cancer mortality may be mitigated by increasing access to high-quality screening and treatment, especially among Black and Native American women, and increasing diversity in clinical trials,” Giaquinto told AuntMinnie.com. The overall breast cancer death rate continuously declined between 1989 and 2022 by 44%.

Disease 111